BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2007
View Archived Issues
Neuromed licenses U.S. rights to OROS Hydromorphone
Read More
Preclinical profile of the kinase inhibitor R-1530 reported by Roche
Read More
Sciele Pharma to acquire Alliant Pharmaceuticals
Read More
Novartis delivers Coartem to Tanzania, continues malaria research
Read More
KSP inhibition with ARRY-520 shows antitumor activity in animal models of solid tumors
Read More
Promising antitumor activity of a novel nonlactone camptothecin derivative
Read More
Novel therapeutic agents for respiratory disorders disclosed in recent patent literature
Read More
Recent patents describe novel agents for psychopharmacological disorders
Read More
BAL-27862 shows promising antitumor activity in multidrug-resistant cancers
Read More
PKD inhibition with CRT-0059359 shows potent inhibition of cancer cell growth in vitro
Read More
Improved series of class I-selective HDAC inhibitors designed by IRBM/Merck
Read More
Novel treatment options for anemia disclosed in recent GSK patents
Read More
Enrollment ongoing in phase III study of Medidur for DME
Read More
VSF-173 studied in phase II for excessive sleepiness
Read More
MP-470 cleared to begin clinical testing
Read More
ALKS-27 begins phase IIa study in COPD
Read More
CHMP to recommend that occult indication be deleted from Visudyne E.U. label
Read More
Exelixis files IND for XL-765
Read More
New pediatric eczema study compares EpiCeram to Elidel
Read More
Findings from confirmatory study of Foscan in advanced head and neck cancer
Read More
BEMA Fentanyl meets primary endpoint in breakthrough cancer pain
Read More
XP-13512 shows improvements in RLS
Read More
CAM-2029 provides long-acting release of octreotide in phase I study
Read More
Preliminary data indicate HyCAMP delivers more cycles of therapy than irinotecan
Read More
Nesp approved in Japan
Read More
Istradefylline NDA filed for Parkinson's disease
Read More
GSK: active start to 2007
Read More